Answers are grounded in this paper and cite their sources.
Retinopathy of prematurity may require treatment with laser photocoagulation or intravitreal anti-vascular endothelial growth factor agents. Although retinal vascularization may continue after anti-vascular endothelial growth factor therapy, the long-term fluorescein angiographic course of peripheral retinal vascular abnormalities after intravitreal aflibercept remains insufficiently characterized. This study aimed to describe long-term fluorescein angiographic changes in eyes with retinopathy of prematurity treated with intravitreal aflibercept monotherapy and to compare peripheral vascular findings between early and late follow-up examinations. This retrospective single-center study included eyes with type 1 retinopathy of prematurity or aggressive retinopathy of prematurity treated with intravitreal aflibercept between 2015 and 2019. Only eyes managed with aflibercept monotherapy without additional intervention were eligible. Early fluorescein angiography was performed at approximately 60 postmenstrual weeks, and late angiography was performed at 47–98 months of chronological age. Images were evaluated for the extent of retinal vascularization and peripheral vascular abnormalities. Early and late angiographic findings were compared using the exact McNemar test for paired categorical variables. Twenty-nine eyes of 18 patients were included. Early follow-up fluorescein angiography demonstrated at least one peripheral vascular abnormality in all eyes. Fine vascularization with blunt termination decreased from 12 eyes (41%) at early follow-up to 0 eyes (0%) at late follow-up ( p < 0.001). Periarteriolar hypoperfusion decreased from 9 eyes (31%) to 0 eyes (0%) ( p = 0.004), and finger-like projection anomaly decreased from 17 eyes (59%) to 9 eyes (31%) ( p = 0.008). Circumferential vascularization remained frequent at late follow-up, being observed in 17 eyes (59%). Persistent avascular retina ≥ 2 optic disc diameters decreased from 6 eyes (21%) to 3 eyes (10%). No fluorescein angiographic evidence of late neovascularization was observed in the included eyes. In this selected cohort of eyes treated with intravitreal aflibercept monotherapy, several early peripheral angiographic abnormalities decreased during long-term follow-up, whereas circumferential vascularization frequently persisted. These findings suggest that peripheral retinal vascular maturation may continue beyond 60 postmenstrual weeks in some eyes. Not applicable.
No takes yet. Share an insight, caveat, or question.
Alkan et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: